Zhang, Fengkui
Shen, Aizong
Ahmed, Waqas https://orcid.org/0000-0002-9035-7614
Pollock, Richard F. https://orcid.org/0000-0002-9873-7507
Funding for this research was provided by:
Pharmacosmos A/S
Article History
Received: 8 August 2024
Accepted: 30 August 2024
First Online: 18 September 2024
Declarations
:
: Richard F. Pollock is a full-time employee, director, and shareholder in, and Waqas Ahmed is a full-time employee of, Covalence Research Ltd, which received consultancy fees from Pharmacosmos A/S to develop the patient-level simulation model and analysis and to prepare the manuscript. Fengkui Zhang and Aizong Shen have no competing interests to declare.
: The present study is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.